NEW YORK (GenomeWeb News) – The Broad Institute of MIT and Harvard has bought 22 new Genome Analyzers, nearly doubling its stock of the Illumina-made sequencers, the company said today.
Broad conducts a wide range of biomedical genomics projects, and has worked in a partnership with the San Diego-based life sciences company. Before this purchase, Broad already had 25 of the analyzers in its tool shed, the company said.
In the coming year, Illumina said that it plans to increase the throughput of the analyzer to as much as 95 gigabases of DNA sequence data per run.
The analyzer is used in research projects such as profiling and discovering novel transcripts, creating high-resolution genome-wide maps of DNA-protein binding sites, and sequencing human genomes at greater than 30-times coverage.
Financial terms of the agreement were not released.